Dengue is a neglected disease, one that is responsible for 22,000 deaths each year in areas where it is endemic. Despite the tremendous efforts invested in research for dengue treatments, no vaccine or antiviral has reached the market, and disease treatment is limited to supportive care. Among strategies that have been used in the search for and development of an antiviral against dengue, the inhibition of viral enzymes has been proven to be the most successful approach. This review covers the major progresses that have been published concerning compounds that inhibit viral enzymes.
dengue; antivirus, NS3 (non-structural 3); NS5 (non-structural 5); viral enzymes
